NYSE · Pharmaceutical Preparations

Johnson & Johnson (JNJ)

Johnson & Johnson's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.

Track JNJ free Write a thesis on JNJ

Last close

$272.03

+0.31% 1 day+53.0% 52 weeks

As of Sep 28, 2026, end of day (IEX). Not a live quote.

JNJ · one year of daily closes

Sep 25, 2025 to Sep 28, 2026 · end of day · IEX

Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

1-day change: +0.31%; From $271.20 the session before
52-week change: +53.0%; Close vs close ~252 sessions earlier
52-week range: $179.71–$278.45; Lowest and highest closing prices
Market cap: $655.6B; Last close × shares outstanding (SEC)
Revenue (TTM): $97.9B; 12 months to Jun 28, 2026
Net income (TTM): $21.0B; 12 months to Jun 28, 2026
Diluted EPS (TTM): $8.62; 12 months to Jun 28, 2026

Financials: trailing twelve months from Johnson & Johnson’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 28, 2026.

Recent SEC filings

Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All JNJ filings on EDGAR

Next earnings

~Oct 13, 2026Estimated

Past results were usually filed before the open

Estimated from past filing dates. Johnson & Johnson hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.

Estimated from SEC EDGAR filing dates

Insider activity (last 90 days)

Open-market buys: 0; filings · 0 shares
Open-market sales: 6; filings · 259,340 shares

Latest 5 of 6 filings shown.

Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.

Insider share counts and prices are as reported on Form 4.

With a free Vero account

What Vero tracks about Johnson & Johnson

Each new Johnson & Johnson filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own JNJ, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.

Track JNJ free Write a thesis on JNJ

The free plan follows 3 stocks, with no card and no end date.

Johnson & Johnson (JNJ): questions, answered from the data

When is Johnson & Johnson's next earnings date?

Around Oct 13, 2026 (past results were usually filed before the open), but that is an estimate, not a date Johnson & Johnson has announced. Estimated from past filing dates: Vero projects it from the dates of Johnson & Johnson's past SEC filings (source: Estimated from SEC EDGAR filing dates). Treat it as approximate until the company confirms it.

What was JNJ's last closing price?

JNJ closed at $272.03 on Sep 28, 2026. This is an end-of-day price from trades on the IEX exchange, published the next trading day, not a live quote, and it can differ slightly from the consolidated official close. That was +0.31% from the session before and +53.0% over 52 weeks.

Have Johnson & Johnson insiders bought or sold shares recently?

In the 90 days to Oct 1, 2026, SEC Form 4 shows 0 filings with open-market purchases (0 shares) and 6 filings with open-market sales (259,340 shares). The most recent: Schmid Timothy (EVP, WW Chair, MedTech) reported selling 33,597 shares, filed Sep 4, 2026. Grants, option exercises and tax withholding are not counted. Insider share counts and prices are as reported on Form 4.

What did Johnson & Johnson file with the SEC most recently?

An 8-K filed on Aug 4, 2026: Current report: Executive or director change. Before that, an 8-K on Jul 29, 2026 and an 8-K on Jul 28, 2026. Each filing is linked to the original on SEC EDGAR.

Is this page a recommendation to buy or sell JNJ?

No. It reports public data (end-of-day prices from IEX and filings from SEC EDGAR) with the date of each. Vero is a research tool, not a financial adviser, and nothing here is a recommendation to buy or sell any security.

Closes are end of day (IEX), as of each page’s date. Grouped by SEC industry code (SIC).

Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.

Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.

Data as of Oct 1, 2026.